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Abstract 
Background: Trophoblast expressing paternal HLA‑C antigens resemble a semiallograft, and could be rejected 
by maternal CD4+ T lymphocytes. We examined the possible role in human pregnancy of Th17 cells, known to be 
involved in allograft rejection and reported for this reason to be responsible for miscarriages. We also studied Th17/
Th1 and Th17/Th2 cells never investigated before. We defined for the first time the role of different Th17 subpopula‑
tions at the embryo implantation site and the role of HLA‑G5, produced by the trophoblast/embryo, on Th17 cell 
differentiation.
Methods: Cytokine production by CD4+ purified T cell and T clones from decidua of normal pregnancy, unexplained 
recurrent abortion, and ectopic pregnancy at both embryo implantation site and distant from that site were analyzed 
for protein and mRNA production. Antigen‑specific T cell lines were derived in the presence and in the absence of 
HLA‑G5.
Results: We found an associated spontaneous production of IL‑17A, IL‑17F and IL‑4 along with expression of CD161, 
CCR8 and CCR4 (Th2‑ and Th17‑type markers) in fresh decidua CD4+ T cells during successful pregnancy. There was a 
prevalence of Th17/Th2 cells (producing IL‑17A, IL‑17F, IL‑22 and IL‑4) in the decidua of successful pregnancy, but the 
exclusive presence of Th17 (producing IL‑17A, IL‑17F, IL‑22) and Th17/Th1 (producing IL‑17A, IL‑17F, IL‑22 and IFN‑γ) 
cells was found in the decidua of unexplained recurrent abortion. More importantly, we observed that Th17/Th2 
cells were exclusively present at the embryo implantation site during tubal ectopic pregnancy, and that IL‑4, GATA‑3, 
IL‑17A, ROR‑C mRNA levels increased in tubal biopsies taken from embryo implantation sites, whereas Th17, Th17/Th1 
and Th1 cells are exclusively present apart from implantation sites. Moreover, soluble HLA‑G5 mediates the develop‑
ment of Th17/Th2 cells by increasing IL‑4, IL‑17A and IL‑17F protein and mRNA production of CD4+ T helper cells.
Conclusion: No pathogenic role of decidual Th17 cells during pregnancy was observed. Indeed, a beneficial role 
for these cells was observed when they also produced IL‑4. HLA‑G5 could be the key feature of the uterine micro‑
environment responsible for the development of Th17/Th2 cells, which seem to be crucial for successful embryo 
implantation.
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Background
The conceptus, because of the presence of paternal clas-
sical MHC class I antigens (HLA-C) [1], is thought to 
resemble a semiallograft [2]. Paternal antigens expressed 
by trophoblast could be processed and presented, 
together with self MHC class II, to the specific maternal 
CD4+ T helper cells by maternal antigen presenting cells 
(APCs). Consequently, the activated maternal effector 
CD4+ T helper cells could release various cytokines.
On the basis of the cytokines produced, the human 
effector CD4+ T helper cells have been classified as T 
helper (Th)1, (Th)2 and, more recently, as (Th17) cells 
[3, 4]. Indeed, CD4+ Th1 cells, which produce interleu-
kin (IL)-2, tumor necrosis factor (TNF)-α and interferon 
(IFN)-γ are the main effectors of phagocyte-mediated 
host defense, which is highly protective against infections 
sustained by intracellular parasites. On the other hand, 
CD4+ Th2 cells, which are mainly responsible for phago-
cyte-independent host defense against extracellular para-
sites, including nematodes, produce IL-5 (promoting the 
growth and the differentiation of eosinophils) and IL-4 
(which together with IL-13 stimulates IgE and IgG1 anti-
body production and inhibits several macrophage func-
tions) [3]. An additional subset of CD4+ T helper cells 
identified as Th17 produces IL-17A, IL17F, IL-21, IL-26 
and IL-22 [4–6]. There is an increasing body of evidence 
showing that Th17 cells constitute a novel Th cell lineage 
distinct from Th1 and Th2 cells [4]. It has been reported 
that the transcription factor retinoic-acid-related orphan 
receptor (ROR)-C is important for the generation of 
Th17 cells in  vitro and in  vivo [7]. Human Th17 cells 
appear to be quite different from mouse Th17 cells in that 
TGF-β1 and IL-6 are not required for generation of Th17 
cells. To date, the most effective cytokines to enhance the 
generation or expansion of human Th17 cells are IL-1β 
and IL-23 [8, 9]. In addition, cytokines such as IL-23 and 
IL-21 promote the generation or proliferation of Th17 
cells, whereas others such as IFN-γ, IL-4, and IL-27, seem 
to suppress their generation [5, 6, 8, 10, 11]. The major 
role of Th17 is the protection against extracellular bacte-
ria by activating epithelial cells, macrophages, fibroblasts 
and endothelial cells, which produce chemokines and 
cytokines responsible for granulocyte recruitment, which 
contributes to chronic tissue inflammation. The patho-
genic role of Th17 cells has been suggested in several 
murine models of chronic inflammatory disorders, such 
as experimental autoimmune encephalomyelitis (EAE) 
[11], collagen-induced arthritis [9], and bowel inflamma-
tory disorders [12].
Importantly for pregnancy, Th1-type and Th17-type T 
helper cells seem to play a role in acute allograft rejec-
tion [13–18], whereas Th2 T helper cells [15] and CD4+ 
CD25+Foxp3+ T reg cells act to enhance allograft 
tolerance [19]. Although the mechanisms of action of 
Th1- and Th2-type cytokines produced by maternal 
CD4+ T helper lymphocytes present at the fetomater-
nal interface are defined with respect to conceptus toler-
ance/pregnancy maintenance or are conceptus rejection/
failure of pregnancy [20–24], the mechanisms of action 
of CD4+CD25+Foxp3+ T reg cells present during 
human pregnancy are not so clear [25]. It was suggested 
in human pregnancy that T reg cells could inhibit the 
majority of human T cells that spontaneously proliferate 
and produce IFN-γ [26]. Kallikourdis et al. [27] reported 
that paternal alloantigen enhanced the accumulation of 
CCR5+ effector Treg cells in the murine pregnant uterus. 
Shima et al. [28] also reported that paternal antigen-spe-
cific Ki67+ proliferating Treg cells expressed CCR5 on 
their surface. These findings suggest that CCR5+ pro-
liferating T cells might induce paternal antigen-specific 
tolerance in humans. However, recently Inada et al. [29] 
reported that the frequencies of CCR5+ Treg cells did not 
change in miscarriage. Unexpectedly, this study showed 
that the frequencies of CCR5+ Treg cells and Ki67+ Treg 
cells are similar in cases of normal pregnancy, miscar-
riage with a normal embryo, and miscarriage with an 
abnormal embryo, suggesting that decidual T reg specific 
for paternal antigens could be not responsible for the 
success of pregnancy by inducing fetal allograft tolerance. 
Accordingly, in mice it seems that T reg cells are acti-
vated in the uterine lymph nodes in response to semen 
and seminal antigens, not spermatozoa antigens and they 
home back to the uterus where they prepare the endome-
trium for implantation [30]. Presumably, the T reg cells 
in part act to dampen uterine inflammation, which is 
induced by semen and is independent of placental anti-
gen exposure.
In the transplant setting, it was widely believed that 
allograft rejection is predominantly a Th1-mediated 
immune response, and that Th2-type cytokines inhib-
iting the Th1 responses improve allograft tolerance. It 
has been shown that a new T helper cell subpopulation, 
known as Th17 has a role in early stage allograft acute 
rejection [13, 14]. Therefore, the role of Th17 cells in con-
ceptus rejection pregnancy failure has been investigated. 
Early evidence suggests that excessive Th17 activity 
may promote miscarriage. The number of Th17 CCR6+ 
cells is increased in the peripheral blood and decidua of 
patients with unexplained recurrent miscarriage com-
pared to healthy control subjects, whereas T reg cells 
are decreased [31]. Accordingly, it has been shown that 
IL-27, a key regulator of T cell responses suppressing in 
particular Th17 cells, is lower in deciduas of patients with 
unexplained recurrent abortion compared to spontane-
ous abortion and controls subjects [32]. An accumula-
tion of Th17 cells has also been found in the decidua of 
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spontaneous abortion cases [33], and the number of 
decidual IL-17+ cells in inevitable abortion cases involv-
ing active genital bleeding was significantly higher than 
that in normal pregnancy. However, it seemed that there 
were no significant differences in the number of decidual 
IL-17+ cells between missed abortion cases without gen-
ital bleeding and normal pregnancy subjects. These last 
results suggest that IL-17+ cells might be involved in the 
induction of inflammation in the late but not the early 
stages of abortion [33]. Thus, the role of Th17 cells in the 
induction of spontaneous abortion remains unclear.
It has been reported that virtually all human memory 
Th17 cells are contained within the CD161+ fraction of 
circulating and tissue-infiltrating CD4+ T cells [10, 12]. 
Interestingly, human Th17 cells express molecules dis-
tinct from Th1 cells, such as IL-23R and RORC, but other 
molecules are shared with Th1 cells, such as the T-box 21 
(TBX21) and IL-12Rβ2. Furthermore, a portion of human 
IL-17A-producing cells were found to also produce IFN-γ 
(they are named Th17/Th1) and both Th17 and Th17/Th1 
exhibit plasticity towards Th1 cells in response to IL-12 
produced in by APCs [11]. This plasticity of Th17 cells to 
Th1 cells has recently been observed even in mice, where 
it was found to be related to the activity of IL-12, or the 
prolonged exposure to IL-23 of Th17 cells [34]. Thus, 
naive CD4+ CD161+ T cells that behave as precursors 
of Th17 cells [10] could differentiate into Th17, Th17/
Th1 and finally into Th1 cells, in response to cytokines 
present in the microenvironment of CD4+ T cells. The 
association of IL-17 and IL-4 production by CD4+ T 
helper cells has also been observed recently in allergic 
disorders [35]. A small proportion of CCR6(+)CD161(+)
CD4(+) T cell clones showed the ability to produce both 
IL-17A and IL-4 (Th17/Th2). Th17/Th2 clones also pro-
duced IL-5, IL-13, IL-21, and IL-22 and displayed the 
ability to induce the in  vitro secretion of IgE. Very few 
Th17/Th2 cells were found among circulating CD4(+) T 
cells from normal subjects (0.04 %), but their proportions 
were significantly increased in the circulation of patients 
with chronic asthma (1.3  %). Th17/Th2 cells could not 
be derived from naive umbilical cord blood CD4(+) T 
cells under any experimental condition. However, when 
circulating memory CCR6(+)CD161(+)CD4(+) T cells 
were cloned under appropriate polarizing conditions, 
Th17/Th2 clones originated in the presence of IL-4, sug-
gesting that an IL-4-rich microenvironment may induce 
the shifting of memory Th17 cells into Th17/Th2 cells.
The aims of our study were (1) to define the role of 
Th17 cells in pregnancy, in particular to investigate if, as 
was reported by Wang et al. [31], these cells are respon-
sible for miscarriages; (2) to define to which Th17-type 
subpopulation (Th17/Th1 or Th17/Th2 cells) the decidual 
Th17 cells belong and to ascertain whether one of these 
two Th17-type profiles is preferentially associated with 
pregnancy failure or successful pregnancy; (3) to find a 
putative soluble factor present at the fetomaternal inter-
face responsible, at least in part, for the differentiation of 
decidual CD4+ T cells into Th17/Th2 cells.
Methods
Subjects
Among the 36 pregnant women studied (Table  1), 30 
pregnant women, agreed to participate to the study at 
Hôpital Paule de Viguier, Toulouse, France. An additional 
six pregnant women suffering from ectopic pregnancy 
agreed to participate in the study at Hospital of Rijeka, 
Croatia. All subjects received verbal and written informa-
tion about the aim and the design of the research, and all 
pregnant women signed the informed consent. The study 
was approved by local ethics committees of Hôpital Paule 
de Viguier, Toulouse, and by the Medical Faculty, Rijeka. 
Twenty-six pregnant women with normal gestation and 
no spontaneous abortion in their past history (Table 1), 
had requested elective termination. Four women had his-
tories of at least 7 ± 3 (range 4–10) prior first-trimester 
spontaneous abortions, which could not been explained 
on the basis of conventional criteria (normal parental 
chromosomes, hysterosalpengography and hysteroscopy, 
endometrial biopsy, hormonal analysis including FSH, 
LH, estradiol, testosterone, cervical cultures for the pres-
ence of ureaplasma, mycoplasma and chlamydia, lupus 
anticoagulant, anti-phospholipid antibodies, thyroid 
function tests). Specimens of deciduae and peripheral 
blood were obtained at the time of spontaneous abortion 
Table 1 Clinical data from patients (unexplained recurrent abortion, ectopic, pregnancy and controls)
Data are expressed as mean ± SD (range)
a Number of patients with spontaneous abortion in past history, excluding the abortion cases discussed in this study
Normal pregnancy Unexplained recurrent abortion Ectopic pregnancy
n 26 4 6
Age (years) 28 ± 2 (25–35) 29 ± 0.9 (28–30) 32 ± 3 (29–36)
No. of Sp‑aba 0 7 ± 3 (4–10) 0
Gestational age (weeks) 9 ± 1 (8–12) 9 ± 1 (8–11) 8 ± 1 (6–9)
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(at 8–11  weeks of pregnancy with normal karyotype of 
trophoblast). All the women were in excellent health at 
that time, had no history of atopy or allergy and were tak-
ing no medication. Trophoblast-invaded tubal mucosa 
at the implantation site and tubal mucosa distant from 
the implantation site was obtained from 6 women (with 
no spontaneous abortion in past history) whose ectopic 
pregnancies were terminated by surgical removal as 
a result of threatened tubal rupture. The mean age and 
the gestational age values of the three groups of patients 
(normal pregnancy, unexplained recurrent abortion 
and ectopic pregnancy) were not statistically different 
(Table 1).
Isolation of purified CD4+ T cells from peripheral blood 
and decidua basalis of early pregnant women
Samples of decidua basalis were obtained from healthy 
pregnant women undergoing vaginal elective termina-
tion of pregnancy (8–12 weeks of gestation with normal 
karyotype of trophoblast). Decidual mononuclear cells 
were isolated from the decidua basalis by collagenase 
digestion and gradient centrifugation as previously 
described [36]. Decidual CD4+ T cells were purified 
from non adherent cells using MACS CD4 isolation kit 
(positive selection, Miltenyi Biotec, Bergisch Gladbach, 
Germany). Purity was routinely >98 %. Peripheral blood 
(PB) cells from the same pregnant women were obtained 
as described [37]. Peripheral blood-CD4+ T cells were 
purified by using MACS CD4 isolation kit (positive 
selection, Miltenyi Biotec, Bergisch Gladbach, Ger-
many). Purity was >99 %.
Flow cytometry
Freshly isolated decidual CD4+ T and Peripheral blood-
CD4+ T cells were stained simultaneously with CD3-
PE-Cy7, CD4-pacific blue, CD161-APC (BD Biosciences, 
Franklin Lakes, New Jersey) and either CCR3-FITC 
(Miltenyi Biotec, Bergisch Gladbach, Germany), IL-
23R-PerCP, CCR4-mouse PE, CCR8-rat PE, CCR6-PE, 
CCR8-rat-PE, CXCR3 mouse-PE (R&D systems, Min-
neapolis, MN), or CRTH2 rat-PE (Myltenyi Biotech, 
Bergisch Gladbach, Germany) mAbs or their respec-
tive isotype controls: IgG1 mouse PE-Cy7, IgG1 mouse-
pacific blue, IgG1 mouse APC, IgG2a rat-FITC, IgG2b 
mouse-PerCP, IgG1 mouse-PE, IgG2a rat-PE (BD Bio-
sciences, Franklin Lakes, New Jersey), IgG2b-mouse PE, 
IgG2b-rat PE (R&D systems, Minneapolis, MN). Stained 
cells were acquired on a BD Biosciences LSR II flow 
cytometer (BD Biosciences, Franklin Lakes, New Jersey) 
(Data were analyzed with BD Biosciences FACSDiva soft-
ware version 6.2.
Generation of CD4+ T‑cell clones from peripheral blood, 
decidual biopsies of normal pregnancy unexplained 
recurrent abortion, and from Fallopian tube biopsies 
of ectopic pregnancy
Specimen of deciduae (separated from villus with nor-
mal karyotype) and of Fallopian tubes, were washed 
twice in PBS (pH 7.2) and then disrupted in small 
fragments (2–3  mm in diameter). Short-term T-cell 
lines were generated by culturing single fragments for 
one week in 24-well plates (Costar, Cambridge, Mas-
sachusetts) in 2  ml RPMI 1640 supplemented with 
2  mM  l-glutamine, 20  mM l-mercaptoethanol, 10  % 
FCS (complete medium) (Hyclone Laboratories, Logan, 
Utah) and IL-2 (Eurocitus, Milan, Italy) (20  U/ml). 
T-cell clones were then generated from short-term cul-
tures of decidual and tubal T cells derived in the pres-
ence of IL-2, as well as from PBMC obtained from the 
same donors, using to a method described elsewhere 
[22].
Induction of cytokine production by T‑cell clones
To induce cytokine production, 106 T-cell blasts from 
each T-cell clone were cultured in the presence of 
PMA (20  ng/ml; Sigma, St. Louis, MO) plus mono-
clonal antibody against CD3 (100  ng/ml; Ortho Phar-
maceuticals, Raritan, New Jersey). After 36  h, culture 
supernatants were collected, filtered, and stored in ali-
quots at −70°.
Determination of cytokine concentrations in supernatants 
with bead‑based multiplex immunoassays
The quantitative determination of the following 
cytokines: IL-4, IL-5, IL-13, IL-17A, I and FN-γ was per-
formed by a bead-based multiplex immunoassay (Bio-
rad Laboratories, Hercules, CA, USA) and IL-17F and 
IL-22 (Millipore, Billerica, Massachusetts) a Bioplex 
200 system (Biorad Laboratories, Hercules, CA, USA), 
as previously described [38]. In brief, supernatant was 
added to antibody-conjugated beads directed against 
the cytokines listed above in a 96-well filter plate. After 
a 30-min incubation, the plate was washed and bioti-
nylated anti-cytokine antibody solution was added before 
another 30-min incubation. The plate was then washed 
and streptavidin-conjugated PE was added. After a final 
wash, each well was suspended with assay buffer and 
analyzed with the Bioplex 200 system. Standard curves 
were derived from various concentrations of the differ-
ent cytokine standards following the same protocol as the 
supernatant samples. The concentration of each cytokine 
(pg/ml) in each T cell clone supernatant was calculated 
thanks to the Bioplex200 software.
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Cytokine production and mRNA expression 
of antigen‑specific T cell lines in the absence or presence 
of HLA‑G5
Recombinant HLA-G5 protein was purified from spe-
cific transfectant cell culture supernatants as previously 
described [39]. Streptokinase (SK)-specific T cell lines 
were generated from 5 donors as described elsewhere 
[40]. Briefly, 106 PBMC in 2  ml of complete medium 
were stimulated for 5 days with the SK antigen (1000 U/
ml) in the absence or presence of either HLA-G5 (1 µg/
ml) or recombinant human IL-4 (RD System, 200  pg/
ml, Minneapolis) and IL-12 (RD System, 5000  pg/
ml) as controls of cytokine modulation. Human IL-2 
(Eurocetus, Milan) at 20 U/ml was then added and cul-
tures continued for an additional 9 days. Viable T blasts 
were tested for their antigen specificity as follows: T cell 
lines, 2 ×  104 T blasts were seeded in microplates and 
co-cultured for 48  h with irradiated (9000  rad) autolo-
gous PBMC (5 × 104) in the presence of medium alone 
or SK (1000 U/ml). After a 16-h pulse with 0.5 µCi 3H-
TdR (Amersham), cultures were harvested and radioac-
tivity measured by liquid scintillation. The phenotype 
distribution of SK-specific T cells was assessed by flow 
cytometry analysis: the T cell lines were CD4+ cells. 
To induce the cytokine production by T cell lines, 106 T 
blasts from each were cultured in the presence of PMA 
(Sigma, 20  ng/ml, St. Louis, MO) plus anti-CD3 mAb 
(BD Bioscience, 100  ng/ml, Franklin Lakes, New Jer-
sey). After 36 h, culture supernatants were collected and 
stored at −80  °C. IL-4, IL-17A, IFN-γ and IL-17F were 
quantified by bead-based multiplex assay. Values of the 
cytokine content 5 SD over those of control superna-
tants obtained by stimulation of irradiated feeder cells 
alone were considered as an effective secretion.
Quantification by real‑time quantitative RT‑PCR of IL‑4, 
IL‑17A, IL‑17F, IL‑23R, IFN‑γ RORC, and GATA3 mRNA
Total RNA was extracted from freshly isolated PB and 
decidual CD4+ T cells, Fallopian tube biopsies and strep-
tokinase (SK)-specific T cell lines by using Trizol (Invit-
rogen, Carlsbad, CA) and treated with DNase I (Qiagen, 
Venlo, NL). First strand cDNA was prepared from 1–5 µg 
of each RNA sample using Superscript II Reverse tran-
scriptase according to the manufacturer’s instructions 
(Invitrogen). Total RNA was extracted with RNAsy Kit 
and treated with DNase I (Qiagen, Venlo, NL), and cDNA 
was synthetized by using TaqMan Reverse Transcription 
Reagents (Applied Biosystem, Warrington, UK). RT-PCR 
was then performed by using TaqMan methodology, as 
described [40]. Quantitative analysis of IL-4, IL-17A, IL-
17F, IL-23R, IFN-γ, RORC, GATA 3 and β-actin was per-
formed by using assay on Demand (Applied Biosystem, 
Warrington, UK). β-actin was used for normalization.
Statistics
Statistical analyses were performed using SSPS software 
(SPSS, Inc, Evanston, IL). Due to non parametric distri-
bution, all comparisons between cytokine concentrations 
in basal and stimulated conditions were performed by 
Wilcoxon test. Th subpopulations percentages were ana-
lyzed by Chi-square test. A p value of <0.05 was consid-
ered statistically significant.
Results
Associated production of IL‑17 and IL‑4 and expression 
of Th17 and Th2‑type molecules by decidual CD3+CD4+ T 
cells in successful pregnancy
Unstimulated decidual and peripheral blood 
CD4+CD3+ T cells purified from the same 9 pregnant 
women were cultured for 24 h and IL-4, IL-17A, IL-17F 
and IL-22 production was measured in the corresponding 
cell culture supernatants (Fig. 1a). A significant increase 
of IL-4 and IL-17A release (p  =  0.028 and p  =  0.027, 
respectively) was observed in the culture supernatants of 
freshly isolated, unstimulated in vitro decidual CD4+ T 
cells compared to those of peripheral blood CD4+ cells 
from the same pregnant women (Fig. 1a). By contrast, no 
significant increase of IL-17F and IL-22 production was 
detected in the same culture supernatants of decidual 
CD4+ T cells compared to those of peripheral blood 
CD4+ cells from the same pregnant women. These data 
were confirmed by the increased levels of mRNA for 
IL-4, IL-17A and RORC (transcriptional factor of Th17 
cells) expressed by freshly isolated, unstimulated decid-
ual CD4+ T cells compared to those of peripheral blood 
CD4+ cells from the same 3 pregnant women (Fig. 1b). 
These results show a spontaneous, associated production 
of both IL-17A and IL-4 by fresh decidual CD3+CD4+ T 
cells during normal pregnancy.
Th1 cells express CXCR3, whereas Th2 cells express 
CCR4, CCR8 and CRTH2 [41–43]. Recent reports [10, 
12] suggest that Th17 cells express CD161, IL-23 receptor 
(IL-23R) CCR6 and CCR4, as Th2 cells, but not CXCR3 
in human adult peripheral blood or CCR6 in human 
decidua. We compared the associated expression of mol-
ecules expressed by Th17 cells and molecules expressed 
by Th1 and Th2 cells by fresh unstimulated CD3+CD4+ 
T cells purified from decidua and peripheral blood of 
the same pregnant women (Fig. 1c, d). Using multicolor 
flow cytometry analysis, we found that the percentage 
of CD3+CD4+ cells expressing CD161 (p = 0.027) and 
the mean fluorescence intensity (MFI) of CD161 were 
increased in the decidua compared to peripheral blood 
of the same 8 pregnant women (Fig.  1c). More impor-
tantly, this increased expression of CD161 by decidua 
CD3+CD4+ cells is associated with the increased 
expression of CCR4 and CCR8 by decidual CD3 + CD4+ 
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cells compared to the peripheral blood CD3+CD4+ cells 
(Fig.  1d). These results indicate that decidual CD4+ T 
cells spontaneously expressed on their cell membrane 
molecules that characterize Th17 and Th2 cells.
Increased IL‑4, IL‑17A, IL‑17F and IL‑22 production 
by decidual CD4+ T cell clones in successful pregnancy
172 and 55 CD4+ T cell clones were respectively gen-
erated from decidual biopsies and peripheral blood 
obtained from 4 pregnant women (with normal preg-
nancy) who voluntarily underwent an elective termina-
tion of pregnancy. IL-4, IL-17A, IL-17F, IL-22 and IFN-γ 
were measured in the supernatant of the CD4+ T cell 
clones by multiplex bead-based assay.
In normal pregnancy, decidua CD4+ T cell clones 
produce higher levels of IL-4 (p  =  0.0000004), a Th2-
type cytokine, IL-17A (p  =  0.015), IL-17F (p  =  0.023) 
and IL-22 (p = 0.006), three Th17-type cytokines, com-
pared to peripheral blood T cell clones (Fig. 2). By con-
trast, IFN-γ production by T cell clones was decreased 
(p  =  0.0001) in the decidua compared to peripheral 
blood (Fig. 2).
These data confirm the associated production of IL-4, 
IL-17A, IL-17F and IL-22 by decidual CD4+ T cells in 
normal pregnancy, thus showing an association between 
Th2-and Th17-type cytokines by decidual CD4+ T cells 
in normal pregnancy.
Prevalence of Th17/Th2 CD4+ cells in the decidua 
of successful pregnancy whereas of Th17 and Th17/Th1 
cells in the decidua of unexplained recurrent abortion
It has been reported that in “inevitable” spontane-
ous abortion with genital bleeding and in unexplained 
spontaneous abortion, the number of decidual Th17 
Fig. 1 Associated spontaneous production of both IL‑17A and IL‑4 and expression of CD161, CCR8 and CCR4 by fresh decidua CD3+CD4+ T cells 
in successful pregnancy. a Unstimulated decidual and PB CD4+ T cells purified from the same 9 pregnant women were cultured for 24 h and IL‑4, 
IL‑17A, IL‑17F and IL‑22 production (mean ± SEM) was measured. b RT‑PCR of unstimulated decidual and PB CD4+ T cells purified from the same 
3 pregnant women for IL‑17A, IL‑4 and RORC was performed. c, d Th1 cells express CXCR3, whereas Th2 cells express CCR4, CCR8 and CRTH2 and 
Th17 cells express CD161, IL‑23 receptor (IL‑23R) CCR6 and CCR4. The associated expression of molecules expressed by Th17 cells and by Th1 and 
Th2 cells in fresh unstimulated CD4+ T cells purified from decidua and PB of the same pregnant women were analyzed by 4‑color (CD3, CD4, 
CD161 and CCR4 or CCR8 or CXCR3) flow cytometry. c is a representative experiment and d data are represented as mean ± SEM. For a, b and d the 
statistical analysis was performed with Wilcoxon test
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cells increased compared to normal pregnancy [31, 33]. 
Previously, we showed that in normal pregnancy both 
IL-17A, IL-17F and IL-22 are produced by decidua 
CD4+ T helper cells in association with IL-4. How-
ever, these previous experiments did not show whether 
the Th17-type cytokines (IL-17A, IL-17F and IL-22) 
and the Th2-type cytokine, IL-4, are produced by two 
different decidual CD4+ T cell subsets or if the same 
CD4+ T cell simultaneously produces the Th17-type 
and the Th2-type cytokines. In fact, part of human IL-
17A-producing cells were found to also produce IL-4 
(these cells were named Th17/Th2 [35] and other cells 
together with IL-17 can produce interferon (IFN)-γ 
(these cells were named Th17/Th1 [6]. To investigate 
the possibility that in normal pregnancy the same 
CD4+ cell subset can produce IL-17 and IL-4, we 
analyzed not only the percentages of Th1-, Th2-, Th0- 
and Th17-cells, but also the percentages of Th17/Th1 
(producing IL-17A,IL-17F, IL-22 and IFN-γ), Th17/
Th2 (producing IL-17A, IL-17F, IL-22 and IL-4) and 
Th17/Th0 (producing IL-17A, IL-17F, IL-22, IL-4 and 
IFN-γ). CD4+ T cell clones were derived from the 
decidua of 4 women with normal pregnancies, who 
underwent an elective termination of pregnancy, and 
from the decidua obtained from 4 women suffering 
from unexplained recurrent abortion (Fig. 3). We found 
that 26  % of the whole CD4+ T cell clones generated 
from normal pregnancy produce IL-17 (54/208 T cell 
clones), whereas 59 % of the whole CD4+ T cell clones 
generated from unexplained recurrent abortion pro-
duce IL-17 (103/174 T cell clones). Thus, according to 
what was reported by Wang [31] and Nakashima [33], 
it seems that the percentage of the whole IL-17-pro-
ducing T cells, without any Th17-type subpopulations 
analysis, is higher in unexplained recurrent abortion 
compared to normal pregnancy (p  =  0.000001). We 
found that all the Th17, Th17/Th2 and Th17/Th1 T cell 
clones produced IL-22. There is no significant differ-
ence between the percentage of Th1,  Th0 and Th17/
Th0 CD4+ T cell clones generated from the decidua 
of normal pregnancy and those generated from spon-
taneous abortion (Fig.  3a). In contrast, the percentage 
of “proper” decidual Th17 (producing only IL-17A, 
IL-17F and IL-22) (p =  0.000001) and decidual Th17/
Th1 (producing IFN-γ plus IL-17A, IL-17F and IL-22) 
T cell clones (p = 0.00001) were significantly higher in 
Fig. 2 Significant increase of both IL‑4 and IL‑17A production by CD4+ T cell clones in decidua compared to PB in successful pregnancy. 172 and 
55 CD4+ T cell clones were respectively generated from decidual biopsies and peripheral blood obtained from 4 pregnant women who underwent 
an elective termination of pregnancy. IL‑4, IL‑17A, IL‑17F, IL‑22, and IFN‑γ (mean ± SEM) were measured in the supernatant by multiplex bead‑based 
assay. The statistical analysis was performed with Wilcoxon test
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unexplained recurrent abortion compared to normal 
pregnancy (Fig. 3a). Noteworthy is the observation that 
no “proper” Th17 and Th17/Th1 T cell clones were ever 
detected in normal pregnancy decidua. However, the 
percentages of Th2 (p =  0.00001) and Th17/Th2 (pro-
ducing IL-4 plus IL-17A, IL-17F and IL-22) (p = 0.001) 
T cell clones were significantly higher in the decidua of 
normal pregnancy compared to decidua of women suf-
fering from unexplained recurrent abortion (Fig. 3a).
Measuring the levels of IL-17A and IL-17F produced 
by the whole IL-17-producing CD4+ T cell clones 
obtained from normal pregnancy (54 T cell clones) 
and by the whole IL-17-producing CD4+ T cell clones 
obtained from unexplained recurrent abortion (103 T cell 
clones), we did not find a significant increase in IL-17A 
and IL-17F production by CD4+ T cell clones generated 
from the decidua from unexplained recurrent abortion 
compared to the IL-17A and IL-17F production by CD4+ 
T cell clones generated from the decidua of successful 
pregnancy (Fig. 3b). Similarly we did not find a significant 
increase in IL-17A and IL-17F production by CD4+ T 
cell clones generated from peripheral blood of successful 
pregnancy and recurrent spontaneous abortions (Addi-
tional file  1). These results also indicate that spontane-
ous recurrent abortions are not necessarily associated 
with increased levels of IL-17A and IL-17F produced by 
CD4+ T cells. Moreover, we measured the levels of IL-17 
produced by Th17/Th2 T cell clones in normal pregnancy 
(18 % of T cell clones) and unexplained recurrent abor-
tion (4.5 % of T cell clones), and we found that the levels 
of IL-17A produced by Th17/Th2 cells in successful preg-
nancy is higher (9507 ± 7000 pg/ml) compared to the lev-
els of IL-17A produced by Th17/Th2 cells in unexplained 
recurrent abortion (137 ± 80 pg/ml) (p = 0.0001). These 
Fig. 3 Prevalence of Th17/Th2 cells in the decidua of successful pregnancy but of Th17 and Th17/Th1 cells in the decidua of unexplained recurrent 
abortion. a Analysis of the percentages of Th1‑, Th2‑, Th0‑, Th17‑cells and of Th17/Th1, Th17/Th2 and Th17/Th0 in CD4+ T cell clones derived from 
the decidua of four women with normal pregnancy, and from the decidua obtained from four women suffering from unexplained recurrent abor‑
tion. Data are represented as mean ± SEM. The statistical analysis was performed with Chi‑square test. b 54 and 103 CD4+ T cell clones were gener‑
ated respectively from the decidua of 4 women with normal pregnancy, and from the decidua obtained from 4 women suffering from unexplained 
recurrent abortion. IL‑17A, IL‑17F and IL‑22 (mean ± SEM) were measured in the supernatant by multiplex bead‑based assay. The statistical analysis 
was performed with Wilcoxon test
Page 9 of 14Lombardelli et al. Clin Mol Allergy  (2016) 14:1 
results confirmed that high IL-17 production is not asso-
ciated with spontaneous recurrent abortion.
We demonstrated that IL-17A, IL-17F, IL-22, together 
with IL-4, were produced by the same decidual CD4+ T 
cell subpopulation (the Th17/Th2 cells) in normal preg-
nancy and not by two different CD4+ T cell subsets. 
Thus, IL-17 production by decidual CD4+ T cells does 
not seem to be associated with spontaneous abortion or 
unexplained spontaneous abortion, as was reported [31, 
33]. IL-17 produced by decidual CD4+ T cells, if asso-
ciated with IL-4 production, is not deleterious for preg-
nancy outcome.
Th17/Th2 CD4+ T cells are exclusively present at the 
implantation site of ectopic pregnancy
Decidual Th17/Th2 cells seem to be important for nor-
mal pregnancy development. We wondered whether 
these cells were present at the implantation site of the 
embryo and thus could have an important role for 
embryo implantation. To answer this question, we per-
formed the same kind of cytokine analysis in ectopic 
tubal pregnancies.
We evaluated not only the percentage of Th1-, Th2-, 
Th0- and Th17-cells, but also the percentages of Th17/
Th1 (producing IL-17A, IL-17F, IL-22 and IFN-γ), Th17/
Th2 (producing IL-17A,IL-17F, IL-22 and IL-4) and 
Th17/Th0 (producing IL-17A, IL-17F, IL-22, IL-4 and 
IFN-γ) among the CD4+ T cell clones derived from the 
implantation site of the embryo (N = 133) and those dis-
tant from the implantation site in the same fallopian tube 
(N = 62) of 3 women suffering from ectopic pregnancy.
There is no significant difference in the percentage of 
pure Th2 and pure Th0 CD4+ T cell clones generated 
from the implantation site and distant from the implan-
tation site (Fig.  4a). At the implantation site the per-
centage of Th17/Th2 (p  =  0.000001) and of Th17/Th0 
(p = 0.000001) CD4+ T cell clones is higher than those 
clones distant from the implantation site. Conversely, the 
percentage of Th1(p = 0.00001), pure Th17 (p = 0.00001) 
and Th17/Th1 (p  =  0.000001) is higher apart from the 
implantation site compared to the embryo implantation 
site where these 3 types of CD4+ T cells are not pre-
sent (Fig. 4a). Thus, Th17/Th1 cells are present only out-
side the implantation site or, as seen above, in decidua 
of recurrent spontaneous abortions. In other words, it 
seems that Th17/Th1 and pure Th17 cells, together with 
Th1 cells, are observed at locations where no implanta-
tion of the embryo occurs or when the implantation 
failed or is not maintained. By contrast, Th17/Th2 are 
prevalent in normal pregnancy and exclusively present at 
the implantation site of the embryo.
The levels of IL-4 (p = 0.00000001), IL-17A (p = 0.003), 
IL-17F (p = 0.00001) and IL-22 (p = 0.00002), produced 
by the CD4+ T cell clones at the implantation site are 
higher than the levels of these cytokines distant from 
the implantation site (Fig.  4b), indicating that there is 
an increase of production of Th2-type and Th17-type 
cytokines at the implantation site.
We confirmed these results by determining mRNA 
expression in Fallopian tube tissue taken at the embryo 
implantation site and tissue sampled distant from the 
implantation site of 3 women suffering from ectopic 
pregnancy (Fig.  4c). At the implantation site, the lev-
els of mRNA for Th2-type molecules (IL-4 and GATA3) 
and for Th17-type molecules (IL-17A and RORC) were 
increased compared to the mRNA levels for these mol-
ecules distant from the implantation site. In contrast, 
distant from the implantation site mRNA production of 
IFN-γ is increased compared to those expressed at the 
embryo implantation site (Fig. 4c).
Soluble HLA‑G5 mediates the development of Th17/Th2 
cells by increasing IL‑4 and IL‑17A production of the CD4+ 
T helper cells
We can speculate about the origin of the factor(s) present 
in the uterine microenvironment that is able to induce 
Th17/Th2 cells by increasing the production of both IL-4 
and IL-17A of the CD4+ T helper cells. Years ago, we 
reported that progesterone could induce Th2 responses 
[44]. Recently it has been shown that progesterone inhib-
its IL-17 production [45]. Thus, progesterone cannot be 
the factor responsible for Th17/Th2 cell development. 
Very recently, we showed that soluble HLA-G5 induces 
an increased production of IL-4 by CD4+ T helper cells 
[40]. We wondered if HLA-G5 could also induce IL-17A 
production by the CD4+ T cells and could be the factor 
responsible for the development of Th17/Th2 cells at the 
implantation site in normal pregnancy.
To investigate the possible influence of HLA-G5 on 
IL-4 and IL-17 production of antigen-specific T cells, we 
generated streptokinase (SK)-specific T cell lines (TCL) 
from 5 donors cultured in the absence or presence of 
HLA-G5. As a control, peripheral blood mononuclear 
cells from the same donors were stimulated with SK in 
the presence of IL-4, a powerful inducer of Th2 differ-
entiation [46] and IL-12, a potent inducer of Th1 differ-
entiation [47], which indicate that SK-specific TCL are 
modulated in our culture conditions (data not shown). 
When we measured the cytokines present in the super-
natants of SK-specific T cell lines, we found a significant 
increase of IL-4 secretion (p = 0.0001) by the SK-specific 
T cell lines in response to IL-4, and a significant increase 
of IFN-γ (p  =  0.006) in response to IL-12 (data not 
shown). This suggests that the culture conditions were 
satisfactory for the modulation of the T cell line cytokine 
profile.
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A statistically significant increase of IL-4 (p = 0.0002), 
IL-17A (p = 0.005) and IL-17F (p = 0.028) was observed 
with the SK-specific T cell lines generated in the presence 
of HLA-G5 1 µg/ml (Fig. 5a). In contrast, IFN-γ produc-
tion in response to HLA-G5 was not statistically sig-
nificant (Fig. 5a). We then analyzed the cytokine mRNA 
levels of SK-specific T cell lines by RT-PCR (Fig. 5b). A 
statistically significant increase of IL-4 (p  =  0.042), IL-
17A (p = 0.043), IL-17F (p = 0.042) and IL-23R (receptor 
expressed by Th17 cells) (p =  0.043) mRNA expression 
was observed with the SK-specific T cell lines generated 
in the presence of HLA-G5 compared to the SK-specific 
T cell lines generated in the absence of HLA-G5 (Fig. 5b). 
By contrast, no significant differences were observed 
for IFN-γ mRNA expression between the T cell lines 
generated in the presence or in the absence of HLA-G5 
(Fig. 5b). These findings confirmed the results obtained at 
the protein level.
We derived CD4+ T cell clones from each of the SK-
specific T cell lines of 4 donors (68 T cell clones in the 
absence of HLA-G5 and 87 T cell clones in the pres-
ence of HLA-G5). Subsequent analysis of their ability to 
Fig. 4 Th17/Th2 cells exclusively found at implantation site of ectopic pregnancy. a Percentage of Th1‑, Th2‑, Th0‑ and Th17‑cells, and of Th17/
Th1 and Th17/Th2 and Th17/Th0 among the CD4+ T cell clones derived from the implantation site of embryo (N = 133) and those distant from 
the implantation site in the same fallopian tube (N = 62) of 3 women suffering from ectopic pregnancy. Data are represented as mean ± SEM. b 
Levels of IL‑4, IL‑17A, IL‑17F and IL‑22 produced by the CD4+ T cell clones at the implantation site (N = 133) and distant from the implantation site 
(N = 62). Data are represented as mean ± SEM. c mRNA levels of IL‑4, GATA‑3, IL‑17A, ROR‑C and IFN‑γ in the biopsies taken at embryo implantation 
site and distant from the implantation site in the fallopian tube of three women suffering from ectopic pregnancy. For a, c the statistical analysis 
was performed with Chi‑square test. For b the statistical analysis was performed with Wilcoxon test
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produce IFN-γ, IL-4, IL-22, IL-17A and IL-17F (Fig.  5c) 
was performed. We analyzed the percentages of Th17/
Th1 (producing IL-17A, IL-17F, IL-22 and IFN-γ) and 
Th17/Th2 (producing IL-17A, IL-17F, IL-22 and IL-4) 
and Th17/Th0 (producing IL-17A, IL-17F, IL-22, IL-4 
and IFN-γ) and pure Th17 CD4+ T cell clones derived 
from the SK-TCL modulated in the presence or absence 
of HLA-G5 (Fig. 5c, d).
The percentage of Th17/Th2 CD4+ T cell clones 
increases in the presence of HLA-G5 (p  =  0.000001) 
(Fig.  5c). However, the percentage of Th17/Th1 
(p  =  0.005) and Th17/Th0 (p  =  0.05) T cell clones is 
decreased in the presence of HLA-G5, but there is no 
difference in the percentage of Th17 clones in the absence 
or in the presence of HLA-G5 (Fig. 5c).
The small percentage of Th17/Th2 T cell clones in the 
absence of HLA-G5 (Fig. 5c), prompted us to analyze the 
levels of Th2- and Th17-type cytokines produced by the 
Th17/Th2 T cell clones in the absence and in the pres-
ence of HLA-G5. We measured the cytokines present in 
the supernatants of CD4+ T cell clones derived from the 
SK-specific T cell lines (Fig. 5d). We found a significant 
increase in the secretion of IL-4 (p =  0.04) and IL-17A 
(p = 0.016) by the Th2/Th17 T cell clones derived from 
SK-TCL generated in the presence to HLA-G 5, com-
pared to Th2/Th17 clones derived from SK-TCL without 
Fig. 5 Soluble HLA‑G5 mediates the development of Th17/Th2 cells by increasing IL‑4 and IL‑17A production by the CD4+ T helper cells. a IL‑4, IL‑
17A, IL‑17F and IFN‑γ (mean ± SEM) were measured by bead‑based assays in the supernatants of SK‑specific T cell lines derived in the presence and 
in the absence of HLA‑G5. b mRNA levels (mean ± SEM) of IL‑4, IL‑17A, IL‑17F, IL‑23R and IFN‑γ were measured by RT‑PCR in SK‑specific T cell lines 
derived in the presence and in the absence of HLA‑G5. c CD4+ T cell clones were derived from the 4 SK‑specific T cell lines derived in the presence 
of HLA‑G5 (N = 87) and from the 4 SK‑specific T cell lines derived in the absence of HLA‑G5 (N = 68) of 4 donors and the levels of IFN‑γ, IL‑4, IL‑22, 
IL‑17A and IL‑17F produced by the T cell clones were measured. The percentages of Th17/Th1 and Th17/Th2 and Th17/Th0 and pure Th17 CD4+ T 
cell clones derived from the SK‑TCL modulated in presence or absence of HLA‑G5 were analysed. Data are represented as mean ± SEM. d The levels 
of IL‑4, IL‑17A, IL‑17F and IL‑22 produced by the Th17/Th2 T cell clones in the SK‑specific T cell lines derived in the absence and in the presence 
of HLA‑G5 were measured by bead based assays. Data are represented as mean ± SEM. For a, b and d the statistical analysis was performed with 
Wilcoxon test. For c the statistical analysis was performed with Chi‑square test
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HLA-G5. By comparison, the levels of IL-17F and IL-22 
were not significantly modified (Fig. 5d).
The above findings indicate that HLA-G5 increases the 
production of both IL-17 and IL-4 by antigen-specific T 
cells in response to HLA-G5, thus upregulating the devel-
opment of Th17/Th2 cells found at the site of embryo 
implantation (Additional file 1: Figure S1).
Discussion
Our findings seem to confirm the results reported by 
Wang [31] and Nakashima [33] showing that the percent-
age of IL-17 producing T cells in the decidua of unex-
plained recurrent abortion is higher than the percentage of 
IL-17-producing cells in the decidua of normal pregnancy. 
However, we did not find a significant increase of the IL-17 
production by CD4+ T cell clones generated from the 
decidua of women with a normal pregnancy compared 
to the IL-17 production of CD4+ T cell clones generated 
from the decidua obtained of women suffering from unex-
plained recurrent abortion. Prior investigations [31, 33] 
did not make comparative measurements of IL-17 produc-
tion by decidual CD4+ T cells in normal pregnancy and 
miscarriages and none identified Th17 subpopulations 
able to produce IL-4 or IFN-γ together with IL-17 (Th17/
Th2 and Th17/Th1, respectively). Moreover, Th17 cells at 
the implantation site were never investigated. In the pre-
sent study, we found that the number of IL-17-producing 
CD4+ T cell clones is increased in the decidua of nor-
mal pregnancy compared to peripheral blood, and more 
importantly, we observed an associated production of 
IL-4 and IL-17 by a large number of decidual CD4+ T cell 
clones (18 % of Th17/Th2 clones) in successful pregnancy. 
Accordingly, we found that freshly purified CD4+ T cells 
obtained from decidua of elective terminations of preg-
nancy, which have already been activated by trophoblast 
in vivo as recently demonstrated [40], can produce spon-
taneously and simultaneously IL-17 and IL-4 without any 
additional in  vitro stimulation. The association of IL-17 
and IL-4 production has been observed in allergic disor-
ders known to be characterized by a Th2-type response 
[35], but the percentage of Th17/Th2 cells in periph-
eral blood of healthy subjects is very low (0.04  %) and 
increases only slightly in the peripheral blood of allergic 
patients with chronic asthma (1.3  %). To our knowledge, 
our study demonstrates for the first time a physiologic 
condition, namely successful pregnancy, in which the 
percentage of Th17/Th2 cells is markedly elevated. Inter-
estingly, it was reported that in allergic disorders 0  % of 
Th17/Th2 T cell clones derived from purified peripheral 
blood CD161+CCR6+Th17 cells were obtained, but if 
CD161+CCR6+Th17 cells were cultured in the presence 
of IL-4, the percentage of Th17/Th2 cells increased to 14 % 
[35]. These findings suggest that Th17 cells switch toward 
Th17/Th2 cells, which could be modulated by the strongly 
Th2-type microenvironment induced in particular by high 
concentrations of progesterone in the decidua [44]. Thus, 
our findings contradict those reported by other authors 
[31, 32] who suggested that Th17 cells may promote mis-
carriage and be deleterious for pregnancy because of their 
capacity to induce alloantigens rejection [13]. Our data do 
not support a pathogenic role for IL-17 producing CD4+ 
T cells in pregnancy, rather we suggest that a beneficial 
role of Th17 cells play a beneficial role when they also pro-
duce IL-4 during the first trimester of human pregnancy. 
Furthermore, the Th17/Th2 cells are present only at the 
embryo implantation site. By contrast, Th17/Th1 cells 
and Th17 cells are prevalent, not only when the implan-
tation fails but also when embryo implantation does not 
occur. Th17/Th1 could be involved as a potential cause of 
the abortion or could just be a consequence of this event. 
The functional activity of Th17/Th1 cells may be the result 
rather than the cause of pregnancy failure. Even in this 
case, however, the production of IFN-γ and IL-17, known 
to be involved in allograft rejection, may aggravate the 
situation and accelerate fetal allograft rejection and thus 
spontaneous abortion.
We have also demonstrated that HLA-G5, a factor pre-
sent in the pregnant uterus microenvironment [48] and 
produced by both trophoblast and embryo, is responsi-
ble, at least in part, for the development of Th17/Th2 cells 
which in turn seem to be crucial for successful embryo 
implantation.
Conclusion
Infection-related immunity during gestation, responsible 
for a large number of miscarriages, seems to be preferen-
tially directed towards combating extracellular microbial 
pathogens. During fetal development, interleukin (IL)-23, 
IL-10 and IL-6, as well as T-helper-17 (Th17)-mediated 
immune responses, are upregulated, whereas tumour 
necrosis factor-α (TNF-α) and IL-1β- and Th1-mediated 
immune responses are downregulated in the intrauterine 
environment (in both the fetal compartment and amni-
otic compartment) [49]. We hypothesize that IL-17/IL-4 
producing decidual CD4+ T cells could be beneficial and 
useful for the maintenance of pregnancy, because they 
may promote an adequate response required to protect 
the mother against dangerous extracellular pathogens. In 
addition, the IL-4 produced by these cells together with 
the Th2 cells in the decidua [22] may induce tolerance 
towards paternal HLA-C expressed by the conceptus, 
through the production of IL-4. Moreover, IL-17 could be 
beneficial for successful pregnancy because it could pro-
mote the proliferation and invasion of human extravil-
lous cytotrophoblast [50], important for gestational 
development.
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We postulate that IL-17 could be essential for the suc-
cess of pregnancy at certain stages of pregnancy but not 
so important or deleterious at other stages. The chronol-
ogy of action of IL-17, alone or in association with other 
cytokines, should be further investigated to better under-
stand the mechanisms by which pregnancy may or may 
not be affected by Th17 cells.
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